Biomarin Pharmaceutical Inc. Earnings

Biomarin Pharmaceutical Inc.’s revenue jumped 16.48% since last year same period to $825.41Mn in the Q2 2025. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 10.77% jump in its revenue since last 3-months.

Biomarin Pharmaceutical Inc.’s net profit jumped 124.43% since last year same period to $240.53Mn in the Q2 2025. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 29.54% jump in its net profits since last 3-months.

Biomarin Pharmaceutical Inc.’s net profit margin jumped 92.69% since last year same period to 29.14% in the Q2 2025. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 16.94% jump in its net profit margins since last 3-months.

Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.82 - a -0.81% fall from last quarter’s estimates.

Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current year stand at 0.82.

Biomarin Pharmaceutical Inc.’s earning per share (EPS) jumped 157.14% since last year same period to 1.44 in the Q2 2025. This indicates that the Biomarin Pharmaceutical Inc. has generated 157.14% annual rate of jump in its earning per share (EPS) in the last 4 quarters.